On this page
Overview
Product & regulatory status
FDA-approved prescription products exist for specified thyroid indications. Weight-loss use is specifically warned against.
Active hormone signalling
T3 acts through thyroid-hormone receptors to influence metabolic processes; replacing deficiency and creating excess are different physiological states. [1]
What the evidence shows
A defined replacement role
Cytomel is labeled for thyroid-hormone replacement in hypothyroidism and selected other thyroid indications. It has a narrow therapeutic index, meaning too little and too much can both create clinically important problems. [1]
Combination-trial limits
A randomized crossover study in 32 adults compared levothyroxine with one fixed T4/T3 combination. Quality of life, weight and lipid measures did not improve, while heart rate rose and more participants had elevated T3. Results concern that formulation, not every selected-patient strategy. [2]
What remains unknown
Which people with persistent symptoms might benefit from a carefully monitored alternative remains uncertain. A low-normal T3 result alone does not establish an indication.
Safety
Cardiac and bone effects
Over-replacement can cause tachycardia, arrhythmia, anxiety and reduced bone density. Existing cardiac disease changes the risk assessment. [1]
Other conditions matter
Uncorrected adrenal insufficiency is a contraindication, and thyroid-hormone changes can affect diabetes control. [1]
Immediate versus compounded formulations
Cytomel’s evidence concerns its labeled oral product. A compounded sustained-release or combination preparation needs separate assessment. [1]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [3]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [4]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Can T3 and T4 be compared unit for unit?
They are different hormones with different pharmacology; a product-name or unit comparison is not a conversion plan.
Is feeling stimulated evidence that treatment is right?
Symptoms such as palpitations or insomnia may reflect excessive exposure rather than correction of the underlying problem.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Cytomel prescribing informationUS liothyronine label; replacement indications, obesity warning and over-replacement risks.
- Levothyroxine/liothyronine randomized crossover trial2016 primary study in 32 adults with primary hypothyroidism; compared one fixed combination with levothyroxine alone.
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.